Hit enter to search or ESC to close
Algo Biotechnologies
  • Home Page
  • Our WHY
  • About Us
  • What we do
  • iBRICK
  • Our Pipeline
  • Algo Biotechnologies Updates
  • Contact Us
  • English
All Posts By

operatore

News

Algo Biotechnologies candidata al Premio “Protagonisti dell’innovazione 2026” di INNLIFES nella categoria ESG

News

Our innovation idea is competing in the SME and Startup contest

News

iBRICK Version dedicated to Natural/Bio Product now Available!

News

Drug Candidates for the Treatment of Infectious Diseases

News

Microbial Infections and Wound Healing

News

European Support for iBRICK trademark registration

News

Connect with us, leveraging our 300+ scientific articles published by our team

Recent

  • Our innovation idea is competing in the SME and Startup contest October 28, 2025
  • Algo Biotechnologies candidata al Premio “Protagonisti dell’innovazione 2026” di INNLIFES nella categoria ESG March 26, 2026
  • iBRICK Version dedicated to Natural/Bio Product now Available! March 24, 2022
  • Drug Candidates for the Treatment of Infectious Diseases March 24, 2022
  • Microbial Infections and Wound Healing March 24, 2022

Spin off  UniversitĂ  degli Studi “G. D’Annunzio” Chieti-Pescara

P.IVA: 02692030691

© 2026 Algo Biotechnologies. COMMUNICATION ITALIA - SORA

  • Home Page
  • Our WHY
  • About Us
  • What we do
  • iBRICK
  • Our Pipeline
  • Algo Biotechnologies Updates
  • Contact Us
  • English
    Utilizziamo i cookie per essere sicuri che tu possa avere la migliore esperienza sul nostro sito. Se continui ad utilizzare questo sito noi assumiamo che tu ne sia felice.